Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
Completed · Phase 2 · Has a placebo group
Conditions studied: Pruritus, Atopic Dermatitis
In brief
Kappa-opioid receptors mediate the sensation of itch in animals and humans. Asimadoline is an orally active, selective kappa-opioid receptor agonist and has demonstrated efficacy in several preclinical pruritus models. The purpose of this Phase 2 study is to evaluate the safety, tolerability and clinical efficacy of asimadoline in patients with pruritus associated with atopic dermatitis.
Key facts
- Study ID
- NCT02475447
- Run by
- Tioga Pharmaceuticals
- People needed
- 249
- Starts
- 2015-07-01
- Expected to finish
- 2017-06-01
- Last updated by the study team
- 2017-12-13
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Clinical Research Center of Alabama — Birmingham, Alabama, United States
- Children's Hospital Los Angeles — Los Angeles, California, United States
- Axis Clinical Research — Los Angeles, California, United States
- Tory Sullivan, MD PA — North Miami Beach, Florida, United States
- Park Avenue Dermatology — Orange Park, Florida, United States
- Olympian Clinical Research — Tampa, Florida, United States
- Northwest Clinical Trials — Boise, Idaho, United States
- Sneeze, Wheeze and Itch Associates, LLC — Normal, Illinois, United States
- Forefront Dermatology — Carmel, Indiana, United States
- MediSearch Clinical Trials — Saint Joseph, Missouri, United States
- The Dermatology Group — Verona, New Jersey, United States
- Corning Center for Clinical Research — Corning, New York, United States
- UNC Dermatology and Skin Cancer Center — Chapel Hill, North Carolina, United States
- Wake Forest Baptist Health — Winston-Salem, North Carolina, United States
- Oregon Health and Science University — Portland, Oregon, United States
- University of Pennsylvania, Department of Dermatology — Philadelphia, Pennsylvania, United States
- Temple Itch Center — Philadelphia, Pennsylvania, United States
- Radiant Research, Inc. — Anderson, South Carolina, United States
- Medical Research South — Charleston, South Carolina, United States
- National Allergy and Asthma Research, LLC — North Charleston, South Carolina, United States
- Dermatology Treatment and Research Center, PA — Dallas, Texas, United States
- Sylvana Research Associates — San Antonio, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.